연구동향 분석

Comparison of the size distributions and immunogenicity of human papillomavirus type 16 L1 virus-like particles produced in insect and yeast cells

김형진 조서영 박민혜 김홍진 2018년

논문상세정보
    • 저자 김형진 조서영 박민혜 김홍진
    • 제어번호 106036683
    • 학술지명 Archives of Pharmacal Research
    • 권호사항 Vol. 41 No. 5 [ 2018 ]
    • 발행처 대한약학회
    • 발행처 URL http://www.psk.or.kr
    • 자료유형 학술저널
    • 수록면 544-553 ( 10쪽)
    • 언어 English
    • 출판년도 2018
    • 등재정보 KCI등재
    • 소장기관 부산대학교 중앙도서관 숙명여자대학교 중앙도서관 영남대학교 중앙도서관 영남대학교 중앙도서관 중앙대학교 서울캠퍼스 중앙도서관 중앙대학교 서울캠퍼스 중앙도서관 중앙대학교 서울캠퍼스 중앙도서관
    • 판매처
    유사주제 논문( 0)
인용/피인용

' Comparison of the size distributions and immunogenicity of human papillomavirus type 16 L1 virus-like particles produced in insect and yeast cells' 의 참고문헌

  • Yeast as an expression system for producing virus-like particles: what factors do we need to consider?
    Kim HJ [2017]
  • Thirty years of baculovirus-insect cell protein expression: from dark horse to mainstream technology
    Van Oers MM [2015]
  • Therapeutic antibodies: successes, limitations and hopes for the future
    Chames P [2009]
  • The papillomavirus major capsid protein L1
    Buck CB [2013]
  • The concentration of carbon source in the medium affects the quality of virus-like particles of human papillomavirus type 16 produced in Saccharomyces cerevisiae
    Kim HJ [2014]
  • The composition of the carbon source and the time of cell harvest are critical determinants of the final yield of human papillomavirus type 16 L1 protein produced in Saccharomyces cerevisiae
    Kim HJ [2011]
  • The Choice of resinbound ligand affects the structure and immunogenicity of column-purified human papillomavirus type 16 virus-like particles
    Kim HJ [2012]
  • Simian virus 40 VP1 capsid protein forms polymorphic assemblies in vitro
  • Scalable production of HPV16 L1 protein and VLPs from tobacco leaves
    Zahin M [2016]
  • Refining HPV 16 L1 purification from E. coli: reducing endotoxin contaminations and their impact on immunogenicity
  • Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types
    Rizk RZ [2008]
  • Production of immunogenic human papillomavirus-16 major capsid protein derived virus like particles
    Patel MC [2009]
  • One-step chromatographic purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae
    Kim HJ [2010]
  • Next generation vaccines and vectors: designing downstream processes for recombinant protein-based virus-like particles
    Effio CL [2015]
  • Maturation of the human papillomavirus 16 capsid
    Cardone G [2014]
  • Insect cells as a production platform of complex viruslike particles
    Fernandes F [2013]
  • Identification of a human papillomavirus type 16-specific epitope on the C-terminal arm of the major capsid protein L1
    Carter JJ [2003]
  • Human papillomavirus and cervical cancer
    Crosbie EJ [2013]
  • Human papillomavirus Type16-L1 VLP production in insect cells
    Abdoli A [2013]
  • Highly efficient production of phosphorylated hepatitis B core particles in yeast Pichia pastoris
    Freivalds J [2011]
  • Evaluation of the thermal stability of Gardasil (R)
  • Electron microscopic detection of viruses in cervix papilloma
  • Effects of Downstream Processing on Structural Integrity and Immunogenicity in the Manufacture of Papillomavirus Type 16 L1 Virus-like Particles
  • Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs)
    Mach H [2006]
  • Different applications of viruslike particles in biology and medicine: vaccination and delivery systems
  • Deletion of a major neutralizing epitope of human papillomavirus type 16 virus-like particles
    Ryding J [2007]
  • Current status and future prospects for human papillomavirus vaccines
  • Construction and characterization of virus-like particles: a review
    Zeltins A [2013]
  • Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years
    Einstein MH [2009]
  • Characterization of virus-like particles in GARDASIL (R) by cryo transmission electron microscopy
    Zhao QJ [2014]
  • Characterization of a major neutralizing epitope on human papillomavirus type 16 L1
    White WI [1999]
  • Cervarix (TM), the GSK HPV-16/HPV-18 AS04-adjuvanted cervical cancer vaccine, demonstrates stability upon long-term storage and under simulated cold chain break conditions
    Le Tallec D [2009]
  • Assessing stability and assembly of the hepatitis B surface antigen into virus-like particles during down-stream processing
    Zahid M [2015]
  • Assembly of the Capsid Protein of Red-spotted Grouper Nervous Necrosis Virus during Purification, and Role of Calcium Ions in Chromatography